Advertisement

Topics

AstraZeneca GmbH Company Profile

09:01 EDT 19th October 2017 | BioPortfolio

Forschungsförderpreis – Imaging in Psychiatrie und Psychotherapie Der Preis wird während der DGPPN-Mitgliederversammlung, die im R ahmen des diesjährigen DGPPN-Kongresses in Berlin stattfindet, verliehen und soll für einen Forschungsaufenthalt im Ausland genutzt werden.
Ziel ist es, junge Wissenschaftler aus allen Fachbereichen, die bereits erste Erfahrungen mit Bildgebungsmethoden im Bereich der Psychiatrie und Psychotherapie gesammelt haben, durch einen mehr monatigen Auslandsaufenthalt in einem Labor höchster Exzellenz zu fördern. Dieser Aufenthalt ist innerhalb von zwölf Monaten nach der Preisverleihung durchzuführen. Antragsberechtigt sind alle Jungwissenschaftler (z.B. Mediziner, Psychologen, Physiker), die nicht älter als 35 Jahre sind.

Location

Johannisberger Straße 74 14197
Postfach
140201
Germany

Contact

Phone: (030) 884293 - 0
Fax: (030) 884293 - 41
Email: info@bsmo.de


News Articles [823 Associated News Articles listed on BioPortfolio]

#jobs #lifescience AstraZeneca – Cambridge: GES Supplier Manager – AstraZeneca Sweden, UK or US

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: GES Supplier Manager – AstraZeneca Swede...

AstraZeneca Enters Respiratory Disease mRNA Collaboration with Ethris

MUNICH & GAITHERSBURG, Md.–(BUSINESS WIRE)–Ethris GmbH, a leader in mRNA-based therapeutics with specific expertise in pulmonary disease, today announced a five-year strategic research...

#jobs #lifescience AstraZeneca – Cambridge: Quality Control Analytical BioChemist, AstraZeneca Biologics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Quality Control Analytical BioChemist, AstraZe...

AstraZeneca BioVenture Hub: A new way of building companies fast

Magus Bjorsne, CEO of AstraZeneca's BioVenture Hub, discusses how the capability, experience and expertise of AstraZeneca in helping mature Biotechs transition into product development.

Laufende Fusionskontrollverfahren: Grünthal Pharma GmbH & Co. KG, Aachen (D); Erwerb von bestimmten mit der Marke ZOMIG verbundenen Rechte und Vermögensgegenstände von der AstraZeneca UK Limited, Cambridge (UK)

Datum der Anmeldung:07.06.2017Aktenzeichen:B3-89/17Unternehmen:Grünthal Pharma GmbH & Co. KG, Aachen (D); Erwerb von bestimmten mit der Marke ZOMIG verbundenen Rechte und Vermögensgegenstände von d...

Tim Herpin, AstraZeneca: Achieving scientific leadership and restoring growth

In this interview filmed at BIO Europe in Vienna, Paul Larsmon talks to Tim Herpin, Vice President, Head of transactions, Business development, GPPS, AstraZeneca. They discuss the change in strategy a...

AstraZeneca 2Q: Soriot's In It For The Long Haul

AstraZeneca's CEO used the company's second-quarter earnings call to proclaim his commitment to the business just weeks after rumors spread...   

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

Letter--Prudent Formulary Management or Underutilization of the Novel P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention?

The author is a former employee of AstraZeneca and owns stock in AstraZeneca. The author reports no conflicts of interest related to the subject of this letter.

Efficacy and safety of osimertinib in a Japanese compassionate use program.

Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that targets the T790M mutation of EGFR. In 2016, AstraZeneca conducted a compassionate use pr...

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

This study is to evaluate non inferiority of Eurofarma budesonide nasal spary x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will rece...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Esomeprazole Magnesium DR Capsules 40 mg and Nexium® 40 mg DR Capsules of AstraZeneca LP, USA. Dosing periods of studies w...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [588 Associated Companies listed on BioPortfolio]

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestin...

AstraZeneca Pharmaceuticals LP

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a lead...

AstraZeneca and The Medicines Company

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastro...

AstraZeneca HealthCare Foundation

Established in 1993, the AstraZeneca HealthCare Foundation is a Delaware not-for-profit corporation and a 501(c)(3) entity organized for charitable purposes including to promote p...

AstraZeneca AS

AstraZeneca er et av verdens ledende farmasøytiske selskaper. Vi bruker hvert år ca. 25 milliarder norske kroner på forskning verden over for å utvikle nye medisiner. Dette har resultert i en rekk...

More Information about "AstraZeneca GmbH" on BioPortfolio

We have published hundreds of AstraZeneca GmbH news stories on BioPortfolio along with dozens of AstraZeneca GmbH Clinical Trials and PubMed Articles about AstraZeneca GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AstraZeneca GmbH Companies in our database. You can also find out about relevant AstraZeneca GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record